GEVA has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
The current ratio measures a company's ability to meet its short-term obligations with its most liquid assets. It is calculated as a company's Total Current Assets excludes Inventory divides by its Total Current Liabilities. Synageva BioPharma Corp's quick ratio for the quarter that ended in Dec. 2014 was 18.14.
Synageva BioPharma Corp has a quick ratio of 18.14. It generally indicates good short-term financial strength.
During the past 13 years, Synageva BioPharma Corp's highest Quick Ratio was 29.94. The lowest was 0.13. And the median was 7.83.
The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets.
Synageva BioPharma Corp's Quick Ratio for the fiscal year that ended in Dec. 2014 is calculated as
|Quick Ratio (A: Dec. 2014 )||=||(Total Current Assets||-||Inventory)||/||Total Current Liabilities|
Synageva BioPharma Corp's Quick Ratio for the quarter that ended in Dec. 2014 is calculated as
|Quick Ratio (Q: Dec. 2014 )||=||(Total Current Assets||-||Inventory)||/||Total Current Liabilities|
The quick ratio is more conservative than the current ratio because it excludes inventories from current assets. The ratio derives its name presumably from the fact that assets such as cash and marketable securities are quick sources of cash. Inventories generally take time to be converted into cash, and if they have to be sold quickly, the company may have to accept a lower price than book value of these inventories. As a result, they are justifiably excluded from assets that are ready sources of immediate cash.
In general, low or decreasing quick ratios generally suggest that a company is over-leveraged, struggling to maintain or grow sales, paying bills too quickly or collecting receivables too slowly. On the other hand, a high or increasing quick ratio generally indicates that a company is experiencing solid top-line growth, quickly converting receivables into cash, and easily able to cover its financial obligations. Such companies often have faster inventory turnover and cash conversion cycles.
The higher the quick ratio, the better the company's liquidity position.
Synageva BioPharma Corp Annual Data
Synageva BioPharma Corp Quarterly Data